NCT00000693View on ClinicalTrials.gov

Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1992

Conditions

Cytomegalovirus RetinitisHIV Infections

Interventions

DRUG

Zidovudine

DRUG

Acyclovir

Trial Locations (2)

60611

Northwestern Univ Med School, Chicago

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000693 - Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS | Biotech Hunter | Biotech Hunter